[1]
Boysen, A.K. et al. 2020. Circulating tumor DNA as a marker of minimal residual disease following local treatment of metastases from colorectal cancer. Acta Oncologica. 59, 12 (Aug. 2020), 1424–1429. DOI:https://doi.org/10.1080/0284186X.2020.1806357.